http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100347288-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H21-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-02 |
| filingDate | 1999-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2002-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2002-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100347288-B1 |
| titleOfInvention | Rna sequence specific binding for kanamycin a |
| abstract | The present invention provides an RNA sequence that specifically binds to kanamycin A and a method of selecting high specificity of such RNA sequence, which can be easily used for reverse drug discovery, thereby reducing the cost for new drug development and kanamycin. It is easy to find new target molecules. |
| priorityDate | 1999-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 182.